Harness Therapeutics is a developer of a platform for physiological upregulation of proteins using targeted translation enhancers, SINEUPs.
Harness Therapeutics's investors include Michael J. Fox Foundation, Dementia Discovery Fund, SV Health Investors, Ono Venture Investment, Epidarex Capital.
Harness Therapeutics is headquartered in Cambridge, United Kingdom.
Harness Therapeutics is a developer of a platform for physiological upregulation of proteins using targeted translation enhancers, SINEUPs.
Harness Therapeutics is at the Grant stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Harness Therapeutics — Funding & Investors." VCBacked, June 9, 2026, https://www.vcbacked.co/company/harness-therapeutics. Accessed October 11, 2026.
VCBacked. (2026). Harness Therapeutics — Funding & Investors. Retrieved October 11, 2026, from https://www.vcbacked.co/company/harness-therapeutics
{{cite web |title=Harness Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/harness-therapeutics |website=VCBacked |access-date=October 11, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated